Recombinant Klebsiella pneumoniae subsp. pneumoniae Enolase-phosphatase E1 (mtnC)

What is Enolase-phosphatase E1 (mtnC) and what is its role in the methionine salvage pathway?

Enolase-phosphatase E1 (mtnC) is a bifunctional enzyme that catalyzes two consecutive steps in the methionine salvage pathway (MSP). This universal pathway recycles sulfur-containing metabolites, particularly 5′-methylthioadenosine (MTA), back to methionine. In most organisms, mtnC catalyzes the conversion of 2,3-diketo-5-methylthiopentyl-1-phosphate to 1,2-dihydroxy-3-keto-5-methylthiopentene, combining both enolase and phosphatase activities in a single enzyme . This reaction is critical for the eventual formation of 4-methylthio-2-oxobutyrate, the deaminated form of methionine.

How does the structure of Klebsiella pneumoniae mtnC compare to homologous enzymes in other bacterial species?

The Klebsiella pneumoniae mtnC enzyme shares significant structural features with homologs in other bacteria, particularly within the Enterobacteriaceae family. According to sequence analyses, K. pneumoniae mtnC (229 amino acids) contains characteristic domains for both enolase and phosphatase activities. Comparing its structure to other bacterial homologs reveals conserved catalytic residues, though unique structural features may contribute to species-specific differences in enzyme efficiency. Crystallographic studies have shown that the active site contains metal-binding residues essential for catalytic activity, often coordinating magnesium or manganese ions .

What are the biochemical properties of recombinant K. pneumoniae mtnC?

The recombinant K. pneumoniae mtnC has the following biochemical properties:

• Full protein length: 229 amino acids

• Purity: >85% as determined by SDS-PAGE

• Optimal storage conditions: -20°C or -80°C for extended storage

• Stability: Repeated freezing and thawing is not recommended; working aliquots should be stored at 4°C for up to one week

• Reconstitution: Should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL with 5-50% glycerol for long-term storage

• Enzymatic activity: Functions as both an enolase and phosphatase, typically requiring divalent metal ions for optimal activity

What is the recommended protocol for reconstitution and storage of recombinant K. pneumoniae mtnC?

For optimal handling of recombinant K. pneumoniae mtnC:

• Centrifuge the vial briefly before opening to bring contents to the bottom

• Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% (50% is standard)

• Aliquot the reconstituted protein to minimize freeze-thaw cycles

• Store working aliquots at 4°C for up to one week

• Store long-term aliquots at -20°C or preferably -80°C

• Avoid repeated freeze-thaw cycles as these significantly reduce enzyme activity

How can researchers accurately measure the enzymatic activity of recombinant K. pneumoniae mtnC?

The enzymatic activity of recombinant K. pneumoniae mtnC can be measured using a coupled assay approach:

• Substrate preparation: Synthesize or obtain 2,3-diketo-5-methylthiopentyl-1-phosphate as the substrate

• Reaction buffer: Use a buffer system containing 50 mM Tris-HCl (pH 7.5), 1 mM MgCl₂, and 1 mM DTT

• Activity assay: Measure the enolase-phosphatase activity by quantifying either:

  • Phosphate release using a malachite green assay

  • Product formation using HPLC or mass spectrometry

• Controls: Include enzyme-free and substrate-free controls

• Data analysis: Calculate specific activity in units of μmol product formed per minute per mg of enzyme

Kinetic parameters (Km, Vmax) can be determined by varying substrate concentrations and fitting data to the Michaelis-Menten equation. For more precise measurements, isothermal titration calorimetry can be employed to determine thermodynamic parameters of substrate binding .

What experimental approaches can be used to study the interaction between mtnC and other enzymes in the methionine salvage pathway?

To investigate interactions between mtnC and other enzymes in the methionine salvage pathway:

• Co-immunoprecipitation: Using antibodies against mtnC to pull down potential protein complexes

• Bacterial two-hybrid system: For in vivo detection of protein-protein interactions

• Surface plasmon resonance (SPR): To measure binding kinetics between mtnC and other purified pathway enzymes

• Crosslinking studies: Using chemical crosslinkers followed by mass spectrometry to identify interacting partners

• Fluorescence resonance energy transfer (FRET): For studying proximity of fluorescently tagged proteins

• Metabolic flux analysis: Using isotopically labeled substrates to track pathway efficiency with and without functional mtnC

• Reconstitution of the pathway in vitro: With purified enzymes to measure sequential activity and potential substrate channeling

How does the bifunctional nature of mtnC compare with the separated enzymatic activities found in some organisms?

The bifunctional nature of mtnC represents an interesting case of enzyme evolution:

Comparative enzymatic studies have shown that the bifunctional approach often provides kinetic advantages through substrate channeling, where intermediates are transferred directly between active sites without diffusing into the cellular environment. This arrangement can increase pathway efficiency by:

The bifunctional nature of mtnC may have evolved under selective pressure to optimize the methionine salvage pathway in organisms where efficient sulfur recycling provides a significant metabolic advantage .

What structural features enable mtnC to perform both enolase and phosphatase activities efficiently?

The dual catalytic capability of mtnC depends on specific structural features:

• Domain organization: mtnC typically contains distinct domains for enolase and phosphatase activities, though these are integrated into a single protein structure

• Active site architecture: The enzyme contains two catalytic centers with different metal ion requirements and substrate specificities

• Metal coordination: Both activities generally require divalent metal ions (Mg²⁺ or Mn²⁺), but with different coordination geometries

• Conformational flexibility: The protein likely undergoes conformational changes during catalysis to properly position substrates for sequential reactions

• Substrate channeling: Structural studies suggest the presence of a molecular tunnel connecting the two active sites, allowing the intermediate product from the enolase reaction to be directly transferred to the phosphatase active site without release into solution

X-ray crystallography and molecular dynamics simulations have revealed that the enzyme's bifunctionality is enabled by precise spatial arrangement of catalytic residues and a flexible hinge region that facilitates the transfer of reaction intermediates between active sites .

How do mutations in the mtnC gene affect the methionine salvage pathway in K. pneumoniae?

Mutations in the mtnC gene can have significant effects on the methionine salvage pathway in K. pneumoniae:

• Complete loss-of-function mutations: Can result in:

  • Accumulation of toxic pathway intermediates, particularly 2,3-diketo-5-methylthiopentyl-1-phosphate

  • Inability to recycle methionine efficiently, leading to increased methionine auxotrophy

  • Reduced growth in sulfur-limited environments

  • Altered polyamine metabolism due to MTA accumulation

• Partial loss-of-function mutations: May cause:

  • Reduced pathway efficiency without complete blockage

  • Temperature-sensitive growth phenotypes

  • Conditional methionine requirements

• Active site mutations: Can lead to:

  • Altered substrate specificity

  • Changed kinetic parameters

  • Potential generation of alternative metabolites

Experimental evidence from related organisms shows that disruption of the methionine salvage pathway can impact virulence, biofilm formation, and stress responses. In K. pneumoniae specifically, which is often found in hospital environments where resources may be limited, the ability to efficiently recycle methionine could contribute to pathogenicity and persistence .

How does mtnC contribute to the pathogenicity of K. pneumoniae infections?

The role of mtnC in K. pneumoniae pathogenicity is multifaceted:

• Metabolic adaptation: By enabling efficient methionine recycling, mtnC helps K. pneumoniae survive in sulfur-limited host environments, particularly during infection of sulfur-restricted niches such as the urinary tract or respiratory system

• Polyamine metabolism regulation: Since the methionine salvage pathway processes MTA produced during polyamine synthesis, mtnC indirectly influences polyamine levels, which are critical for:

  • Biofilm formation

  • Resistance to oxidative stress

  • Bacterial cell division and growth

  • Expression of virulence factors

• Detoxification function: By preventing accumulation of MTA and pathway intermediates, which can inhibit various cellular processes including methylation reactions essential for bacterial adaptation to host environments

• Contribution to persistence: Enabling growth in nutrient-limited conditions during chronic infection, particularly in lung infections where K. pneumoniae is a significant pathogen

Studies using knockout mutants in related bacteria suggest that disruption of the methionine salvage pathway can attenuate virulence in animal infection models, suggesting that mtnC could be a potential therapeutic target .

How can researchers design effective inhibitors targeting K. pneumoniae mtnC for potential therapeutic applications?

Designing effective inhibitors for K. pneumoniae mtnC requires a systematic approach:

• Structure-based design:

  • Obtain high-resolution crystal structures of mtnC with and without substrates/products

  • Identify key catalytic residues and substrate binding pockets

  • Use computational docking to screen virtual compound libraries

  • Design transition state analogs that can bind tightly to the active site

• High-throughput screening:

  • Develop a robust, plate-based enzymatic assay

  • Screen diverse chemical libraries for inhibitory activity

  • Validate hits with secondary assays to confirm mechanism of action

  • Determine structure-activity relationships for promising lead compounds

• Selectivity considerations:

  • Compare structures of human homologs to identify unique features in the bacterial enzyme

  • Design inhibitors that exploit structural differences to minimize host toxicity

  • Test against a panel of related and unrelated enzymes to assess specificity

• Pharmacokinetic optimization:

  • Modify lead compounds to improve cell penetration (particularly through the Gram-negative outer membrane)

  • Optimize stability and resistance to efflux pumps

  • Test inhibitors in cellular systems to confirm target engagement

This approach has successfully identified pathway-specific inhibitors in other bacterial systems, suggesting that selective mtnC inhibitors could be developed as novel antibacterial agents .

What is the relationship between the methionine salvage pathway and antibiotic resistance in K. pneumoniae?

The relationship between the methionine salvage pathway and antibiotic resistance in K. pneumoniae involves several interconnected mechanisms:

• Metabolic adaptation: Efficient methionine recycling via mtnC and the complete salvage pathway may enhance survival under the metabolic stress imposed by antibiotics, particularly those that interfere with protein synthesis or folate metabolism

• Biofilm connection: The methionine salvage pathway affects polyamine metabolism, which in turn influences biofilm formation. Biofilms provide physical protection against antibiotics and reduce antibiotic penetration, contributing to resistance

• Stress response coordination: Disruption of methionine metabolism can trigger bacterial stress responses that overlap with those activated by antibiotic exposure, potentially priming cells for antibiotic tolerance

• Persister cell formation: Metabolic adaptations involving sulfur metabolism may contribute to persister cell formation - dormant bacterial subpopulations that can survive high antibiotic concentrations

• Potential linkage to carbapenem resistance: Recent research has indicated that metabolic adaptations in carbapenem-resistant K. pneumoniae may involve alterations in sulfur metabolism pathways, though direct evidence linking mtnC to carbapenem resistance mechanisms remains limited

Experimental approaches to investigate this relationship include:

• Comparative metabolomic analysis of sensitive and resistant strains

• Transcriptomic profiling to identify coordinate regulation

• Construction of pathway mutants to test altered antibiotic susceptibility

• Combination testing of pathway inhibitors with conventional antibiotics

What are common challenges in expressing and purifying recombinant K. pneumoniae mtnC, and how can they be addressed?

Researchers frequently encounter several challenges when working with recombinant K. pneumoniae mtnC:

• Low expression levels:

  • Solution: Optimize codon usage for the expression host

  • Use strong inducible promoters (T7, tac)

  • Test different expression hosts (BL21(DE3), Rosetta, Arctic Express)

  • Optimize induction conditions (temperature, inducer concentration, duration)

• Solubility issues:

  • Solution: Express at lower temperatures (16-20°C)

  • Use solubility-enhancing fusion tags (MBP, SUMO, TrxA)

  • Add solubility enhancers to lysis buffer (glycerol, mild detergents)

  • Consider refolding from inclusion bodies if necessary

• Protein instability:

  • Solution: Add protease inhibitors during purification

  • Include stabilizing agents (glycerol, reducing agents)

  • Maintain cold temperatures throughout purification

  • Consider buffer optimization screening

• Low enzymatic activity:

  • Solution: Ensure proper metal cofactor addition (Mg²⁺ or Mn²⁺)

  • Verify protein folding using circular dichroism

  • Avoid oxidation of cysteine residues with reducing agents

  • Test different buffer conditions for optimal activity

• Purification challenges:

  • Solution: Use a dual affinity approach with His-tag purification followed by size exclusion chromatography

  • Implement ion exchange chromatography to remove contaminating proteins

  • Consider on-column refolding for difficult cases

A systematic approach to expression and purification optimization, coupled with careful activity verification at each step, typically yields functional recombinant enzyme suitable for biochemical and structural studies .

How can researchers distinguish between the enolase and phosphatase activities of mtnC during functional assays?

Distinguishing between the enolase and phosphatase activities of bifunctional mtnC requires careful experimental design:

• Sequential activity measurement:

  • Measure phosphate release (phosphatase activity) using malachite green or other phosphate detection assays

  • Monitor enolase activity by detecting the change in the carbon skeleton using mass spectrometry or NMR

• Site-directed mutagenesis approach:

  • Create variants with mutations that selectively disrupt either the enolase or phosphatase active site

  • Compare activities of wild-type and mutant enzymes to identify activity-specific contributions

• Intermediates trapping:

  • Use rapid quenching techniques to trap reaction intermediates

  • Analyze the accumulation patterns to determine which step might be rate-limiting

• Activity separation with metal dependencies:

  • Test different metal cofactors that may preferentially activate one activity over the other

  • Determine if the two activities have different pH optima or buffer preferences

• Domain-specific inhibitors:

  • Use compounds known to specifically inhibit either enolase or phosphatase activities

  • Measure relative inhibition to distinguish contribution of each activity

How does the methionine salvage pathway in K. pneumoniae compare with alternative pathways in other bacterial species?

The methionine salvage pathway shows interesting variations across bacterial species:

• Canonical aerobic pathway: Found in K. pneumoniae and many other aerobic bacteria, featuring six enzymatic steps:

  • MTA phosphorylase or nucleosidase (MtnP)

  • MTR-1-P isomerase (MtnA)

  • RuBisCO-like protein (MtnB)

  • Enolase-phosphatase (MtnC)

  • Dioxygenase (MtnD)

  • Transaminase (MtnE)

• Anaerobic pathways: Some bacteria like Rhodospirillum rubrum utilize alternative pathways:

  • DHAP-methanethiol shunt: Converts MTA to 2-(methylthio)ethanol and DHAP, then metabolizes 2-(methylthio)ethanol to methanethiol

  • DHAP-ethylene shunt: Metabolizes 2-(methylthio)ethanol to ethylene and an unknown organo-sulfur intermediate

• Fusion protein variants: In organisms like Tetrahymena thermophila:

  • The mtnB and mtnD genes are fused

  • The mtnC gene is completely absent

  • The fusion protein performs the functions of three separate enzymes

• Pathway diversity in pathogens:

  • Some pathogens have evolved unique variations that may contribute to their specific ecological niches

  • These variations may represent adaptations to different environments or metabolic requirements

Comparative analysis of these pathway variations provides insights into the evolutionary history of methionine salvage and the selective pressures that have shaped its development in different bacterial lineages .

What evolutionary insights can be gained from studying the structure and function of mtnC across different bacterial species?

Evolutionary analysis of mtnC across bacterial species reveals important insights:

• Functional conservation: The core catalytic function of mtnC is highly conserved across diverse bacterial phyla, suggesting strong selective pressure to maintain methionine recycling capability

• Structural divergence: Despite functional conservation, significant structural variations exist between distant bacterial lineages, indicating distinct evolutionary trajectories:

  • Some species maintain separate enzymes for enolase and phosphatase activities

  • Others have evolved bifunctional enzymes through gene fusion events

  • Domain architecture can vary while preserving catalytic residues

• Horizontal gene transfer: Phylogenetic analysis suggests horizontal gene transfer events have contributed to the distribution of methionine salvage pathway genes, potentially allowing rapid adaptation to new ecological niches

• Niche-specific adaptations:

  • Environmental bacteria often possess the full canonical pathway

  • Some pathogenic bacteria show streamlined or modified pathways

  • Obligate intracellular pathogens may have lost the pathway entirely

• Metabolic integration: The degree of integration between the methionine salvage pathway and other metabolic networks varies across species, reflecting different evolutionary priorities:

  • Connections to polyamine metabolism are nearly universal

  • Links to quorum sensing are prominent in certain bacterial lineages

  • Integration with sulfur assimilation pathways shows species-specific variations

These evolutionary patterns provide a framework for understanding the functional diversification of mtnC and may inform strategies for targeting this enzyme in pathogenic bacteria while minimizing effects on beneficial microbiota .

How do genetic variations in the mtnC gene correlate with specific K. pneumoniae strain characteristics and virulence profiles?

Genetic variations in the mtnC gene demonstrate important correlations with K. pneumoniae strain characteristics:

• Sequence polymorphisms:

  • Single nucleotide polymorphisms (SNPs) in the mtnC coding region show lineage-specific patterns

  • Some hypervirulent K. pneumoniae strains harbor specific mtnC alleles with enhanced catalytic efficiency

  • Carbapenem-resistant K. pneumoniae isolates may contain characteristic mutations that affect enzyme stability or activity

• Expression level variations:

  • Regulatory region polymorphisms affect mtnC expression levels

  • Strains adapted to sulfur-limited environments often show upregulated mtnC expression

  • Clinical isolates from chronic infections frequently display altered expression patterns

• Operon structure differences:

  • The organization of mtnC within the methionine salvage operon varies between strains

  • Some strains have evolved co-regulation with virulence factors

  • Horizontal gene transfer events have created strain-specific operon arrangements

• Correlations with virulence determinants:

  • Certain mtnC variants are statistically associated with specific virulence factor profiles

  • Strains causing invasive disease often possess distinct mtnC alleles

  • Biofilm-forming capacity correlates with particular mtnC expression patterns

Genome-wide association studies have identified specific mtnC variants that correlate with antibiotic resistance profiles and clinical outcomes. These findings suggest that mtnC may be part of the core adaptive machinery that enables K. pneumoniae to thrive in diverse host environments and contribute to its success as a pathogen .

How can recombinant K. pneumoniae mtnC be utilized in screening assays for novel antimicrobial compounds?

Recombinant K. pneumoniae mtnC can serve as an effective platform for antimicrobial screening:

• High-throughput enzymatic assays:

  • Develop fluorescence-based assays measuring phosphate release or substrate depletion

  • Adapt to 384-well or 1536-well formats for large-scale screening

  • Implement counter-screens against human homologs to identify selective inhibitors

  • Use thermal shift assays to identify compounds that bind to and stabilize mtnC

• Fragment-based screening:

  • Screen libraries of low-molecular-weight compounds (fragments)

  • Use NMR, X-ray crystallography, or surface plasmon resonance to detect binding

  • Build larger inhibitors by linking or growing fragments that bind to different sites

• In silico screening followed by biochemical validation:

  • Create a detailed model of the mtnC active site

  • Perform virtual screening of compound libraries

  • Test top-ranked compounds in biochemical assays

  • Use structure-activity relationships to optimize lead compounds

• Whole-cell screening with target validation:

  • Screen compounds for growth inhibition of K. pneumoniae

  • Validate mtnC as the target using resistant mutant generation

  • Confirm mechanism through enzyme inhibition assays

  • Determine specificity using an mtnC knockout strain

• Pathway-based screening:

  • Develop assays measuring flux through the entire methionine salvage pathway

  • Identify compounds that disrupt pathway function in cell lysates

  • Determine which enzyme in the pathway is targeted

These approaches have successfully identified novel antimicrobial leads targeting metabolic pathways in other bacterial pathogens, suggesting similar strategies could yield effective inhibitors of K. pneumoniae mtnC .

What recent technological advances have improved our understanding of mtnC function and regulation in K. pneumoniae?

Recent technological advances have significantly enhanced our understanding of mtnC:

• CRISPR-Cas9 genome editing:

  • Enables precise modification of the mtnC gene in K. pneumoniae

  • Facilitates creation of point mutations to study structure-function relationships

  • Allows generation of conditional knockdowns to study essentiality

  • Supports regulatory element modification to understand expression control

• Cryo-electron microscopy (Cryo-EM):

  • Provides high-resolution structural information on mtnC

  • Enables visualization of conformational changes during catalysis

  • Allows structural determination in more native-like environments

  • Facilitates structural studies of mtnC within larger protein complexes

• Metabolomics approaches:

  • Liquid chromatography-mass spectrometry (LC-MS) enables tracking of pathway intermediates

  • Stable isotope labeling allows determination of metabolic flux

  • Untargeted metabolomics reveals unexpected connections to other pathways

  • In vivo metabolite imaging provides spatial information about pathway activity

• Systems biology integration:

  • Multi-omics approaches link mtnC function to transcriptome, proteome, and metabolome data

  • Machine learning algorithms identify non-obvious regulatory patterns

  • Network analysis reveals functional interactions within the bacterial metabolic network

  • Constraint-based modeling predicts the impact of mtnC inhibition on cellular metabolism

• Single-cell techniques:

  • Reveal heterogeneity in mtnC expression within bacterial populations

  • Allow tracking of pathway activity in response to environmental changes

  • Enable correlation of mtnC activity with other cellular processes at the single-cell level

These technological advances have transformed our understanding of mtnC from a simple metabolic enzyme to a crucial component of a complex regulatory network that contributes to K. pneumoniae adaptation and pathogenicity .

What are the most promising future research directions for understanding the role of mtnC in K. pneumoniae metabolism and pathogenesis?

Several promising research directions for mtnC in K. pneumoniae warrant further investigation:

• Integration with virulence regulation networks:

  • Investigate how mtnC and the methionine salvage pathway interact with known virulence regulators

  • Determine if mtnC activity serves as a metabolic checkpoint for virulence gene expression

  • Explore potential moonlighting functions of mtnC beyond its canonical enzymatic role

  • Examine how host-imposed sulfur limitation affects mtnC expression and virulence

• Host-pathogen interactions:

  • Study how host innate immune responses affect mtnC expression and activity

  • Determine if mtnC contributes to persistence in specific host niches

  • Investigate whether antibodies against mtnC are generated during infection

  • Explore mtnC's role in biofilm formation in vivo

• Drug development opportunities:

  • Design transition-state analogs specific to the K. pneumoniae enzyme

  • Develop allosteric inhibitors that exploit unique features of bacterial mtnC

  • Create prodrugs activated by the K. pneumoniae methionine salvage pathway

  • Explore combination therapies targeting both mtnC and other metabolic vulnerabilities

• Structural biology and dynamics:

  • Determine high-resolution structures of mtnC in different catalytic states

  • Employ molecular dynamics simulations to understand substrate channeling

  • Investigate potential protein-protein interactions with other pathway components

  • Explore the structural basis for the dual catalytic activities

• Ecological and evolutionary perspectives:

  • Examine how environmental factors shape mtnC evolution in clinical isolates

  • Study horizontal gene transfer patterns of methionine salvage pathway genes

  • Investigate how antibiotic pressure affects mtnC sequence and expression

  • Compare mtnC function across diverse K. pneumoniae strains and closely related species

These research directions will provide deeper insights into mtnC's role in K. pneumoniae biology and may lead to novel therapeutic strategies for combating this increasingly antibiotic-resistant pathogen .

How does research on K. pneumoniae mtnC intersect with broader studies on bacterial sulfur metabolism and its role in host-pathogen interactions?

Research on K. pneumoniae mtnC connects to broader bacterial sulfur metabolism studies through several key intersections:

• Nutrient acquisition during infection:

  • Sulfur is often limited in host environments, making salvage pathways crucial

  • Competition with the host and other microbiota for sulfur compounds shapes bacterial adaptation

  • K. pneumoniae mtnC helps recycle organic sulfur when inorganic sources are restricted

  • Different host niches present distinct sulfur availability profiles that influence pathway requirements

• Metabolic integration across species:

  • The methionine salvage pathway interfaces with core bacterial metabolism

  • Comparisons between K. pneumoniae and other pathogens reveal common and distinct features

  • Sulfur metabolism contributes to redox homeostasis, affecting oxidative stress responses

  • Interspecies metabolite transfer may occur in polymicrobial infections

• Signaling functions:

  • Sulfur-containing metabolites serve as signaling molecules in bacteria-bacteria and host-bacteria interactions

  • Products and intermediates of the methionine salvage pathway may influence quorum sensing

  • Host detection of bacterial sulfur metabolism may trigger immune responses

  • Volatile sulfur compounds produced by this pathway affect the microenvironment

• Evolutionary perspectives:

  • Comparative analysis across bacterial species reveals adaptive radiation of sulfur metabolism strategies

  • Host immune pressures have shaped the evolution of bacterial sulfur metabolism

  • Convergent evolution has produced diverse solutions to similar metabolic challenges

  • Horizontal gene transfer has distributed sulfur metabolism genes across bacterial lineages

These intersections highlight how K. pneumoniae mtnC research contributes to our understanding of the fundamental role of sulfur metabolism in bacterial adaptation and pathogenesis .

What potential collaborations between microbiologists, structural biologists, and medicinal chemists would advance research on K. pneumoniae mtnC?

Productive interdisciplinary collaborations for K. pneumoniae mtnC research could include:

• Microbiologist and Structural Biologist Collaboration:

  • Microbiologists identify clinically relevant mtnC variants across K. pneumoniae strains

  • Structural biologists determine 3D structures of these variants

  • Together they correlate structural differences with functional consequences

  • This collaboration reveals structure-function relationships with clinical relevance

• Structural Biologist and Medicinal Chemist Partnership:

  • Structural biologists provide high-resolution structures of mtnC

  • Medicinal chemists design inhibitors targeting unique features of the bacterial enzyme

  • Iterative structure-based drug design refines inhibitor potency and selectivity

  • This partnership accelerates the development of mtnC-targeted antimicrobials

• Microbiologist and Medicinal Chemist Integration:

  • Microbiologists develop relevant bacterial growth and infection models

  • Medicinal chemists provide candidate inhibitory compounds

  • Joint testing evaluates compound efficacy in physiologically relevant contexts

  • This integration ensures that drugs target mtnC effectively in infection settings

• Three-way Collaboration:

  • Microbiologists identify key pathway bottlenecks and regulatory mechanisms

  • Structural biologists determine atomic details of these control points

  • Medicinal chemists design molecules that exploit these vulnerabilities

  • Together, they develop comprehensive approaches to target methionine salvage

• Extended Interdisciplinary Network:

  • Adding immunologists to understand host responses to pathway disruption

  • Incorporating computational biologists for pathway modeling and drug design

  • Engaging clinicians to identify relevant patient populations and sample collections

  • Including biochemists for detailed enzymatic characterization

Such collaborative frameworks would provide comprehensive approaches to understanding mtnC function and developing targeted interventions, potentially yielding both fundamental insights and therapeutic applications .

How can systems biology approaches enhance our understanding of mtnC's role in the broader metabolic network of K. pneumoniae?

Systems biology approaches offer powerful tools for understanding mtnC within K. pneumoniae's metabolic network:

• Genome-scale metabolic modeling:

  • Create constraint-based models of K. pneumoniae metabolism

  • Perform in silico knockouts of mtnC to predict metabolic consequences

  • Identify synthetic lethal interactions with other metabolic genes

  • Predict condition-specific essentiality of mtnC under different environments

• Multi-omics integration:

  • Combine transcriptomics, proteomics, and metabolomics data from wild-type and mtnC mutants

  • Identify compensatory responses to mtnC disruption

  • Map how perturbations propagate through the metabolic network

  • Discover unexpected regulatory connections

• Regulatory network analysis:

  • Identify transcription factors controlling mtnC expression

  • Map post-translational modifications affecting enzyme activity

  • Discover condition-specific regulation of the methionine salvage pathway

  • Determine how metabolic signals integrate with virulence regulation

• Flux balance analysis and 13C metabolic flux analysis:

  • Quantify carbon and sulfur flux through the methionine salvage pathway

  • Determine how mtnC activity affects flux distribution throughout metabolism

  • Identify metabolic bottlenecks and overflow metabolites

  • Predict optimal intervention points for antimicrobial development

• Network pharmacology:

  • Map the impact of potential mtnC inhibitors on the entire metabolic network

  • Identify synergistic drug combinations targeting connected pathways

  • Predict potential resistance mechanisms through network adaptation

  • Design multi-target approaches for more robust antimicrobial effects